AllianceBernstein
IPSC icon

AllianceBernstein’s Century Therapeutics IPSC Stock Holding History

AllianceBernstein’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3K Buy
+29,790
New +$68.1K ﹤0.01% 3282
2025
Q2 		– Sell
-20,020
Closed -$9.53K – 3275
2025
Q1 		$9.53K Hold
20,020
– – ﹤0.01% 3193
2024
Q4 		$20.2K Hold
20,020
– – ﹤0.01% 3211
2024
Q3 		$34.2K Hold
20,020
– – ﹤0.01% 3207
2024
Q2 		$51.1K Buy
20,020
+8,440
+73% +$26.7K ﹤0.01% 3184
2024
Q1 		$48.4K Hold
11,580
– – ﹤0.01% 3093
2023
Q4 		$38.4K Sell
11,580
-1,100
-9% -$2K ﹤0.01% 3149
2023
Q3 		$25.4K Hold
12,680
– – ﹤0.01% 3166
2023
Q2 		$40.1K Buy
12,680
+1,880
+17% +$6.06K ﹤0.01% 3141
2023
Q1 		$37.5K Buy
+10,800
New +$47.4K ﹤0.01% 3109

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

AllianceBernstein's IPSC Position: Q2 2026 in Review

AllianceBernstein opened a new position in Century Therapeutics (IPSC) in Q2 2026: 29,790 shares worth $67.3K. The stake represents ﹤0.01% of the portfolio and ranks #3282 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in IPSC as recently as Q1 2025.

AllianceBernstein first reported a position in IPSC in Q1 2023 and has held it in 10 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • AllianceBernstein held 29,790 shares of Century Therapeutics worth $67.3K as of Q2 2026.
  • Century Therapeutics was a new AllianceBernstein position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3282 holding.
  • AllianceBernstein first reported a position in Century Therapeutics in Q1 2023 and has held it in 10 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.